Bone Marrow Transplantation

Top Story

FDA issues warnings about fraudulent cancer treatments

April 25, 2017

The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer.

The products — typically marketed and sold on websites or social media platforms — have not received FDA approval.

Eight noteworthy FDA actions

April 21, 2017
The FDA announced several decisions related to hematology and oncology therapies and devices in the past month. HemOnc Today summarizes eight FDA actions that…

Patient education pivotal when recommending palliative care

April 12, 2017
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment, according to results of a…
In the Journals Plus

Physician-aided deaths continue to rise in Oregon

April 6, 2017
The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death with Dignity Act in…
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Video
Meeting News Coverage

VIDEO: Ibrutinib could be ‘game changer’ for GVHD treatment

January 1, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or…

Eight noteworthy FDA actions

April 21, 2017
The FDA announced several decisions related to hematology and oncology therapies and devices in the past month. HemOnc Today summarizes…

Patient education pivotal when recommending palliative care

April 12, 2017
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment…

In the Journals Plus

Physician-aided deaths continue to rise in Oregon

April 6, 2017
The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death…

In the Journals Plus

ASCO: Coordinated effort needed to provide high-quality care to sexual and gender minorities

April 5, 2017
Sexual and gender minorities diagnosed with cancer may encounter specific challenges, including discrimination and greater risks for anxiety and…

FDA News

FDA accepts supplemental application for Imbruvica for treatment of chronic GVHD

April 5, 2017
The FDA accepted for review a supplemental new drug application for ibrutinib for the treatment of patients with chronic graft-versus-host disease…

Meeting News

Biden: Cancer moonshot has ‘evolved from program to movement’

April 3, 2017
International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century…

In the Journals Plus

Annual report: Overall cancer death rates continue to decline, but problem areas persist

March 31, 2017
Overall cancer death rates continued to decrease in men, women and children among all racial and ethnic groups, according to the Annual Report to the…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to…

Leading cancer organizations: Trump’s proposed NIH budget cuts will threaten research, patient care

March 17, 2017
Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s…

More Headlines »
Advertisement
Advertisement